首页> 美国卫生研究院文献>other >Fluorinated NN′-Diarylureas As Novel Therapeutic Agents Against Cancer Stem Cells
【2h】

Fluorinated NN′-Diarylureas As Novel Therapeutic Agents Against Cancer Stem Cells

机译:氟化NN-二芳基脲作为抗癌干细胞的新型治疗剂

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Colorectal cancer (CRC) is the second-leading cause of cancer-related mortality in the United States. Over 50% of patients with CRC will develop local recurrence or distant organ metastasis. Cancer stem cells play a major role in the survival and metastasis of cancer cells. In this study, we examined the effects of novel AMP-activated protein kinase (AMPK) activating compounds on CRC metastatic and stem cell lines as potential candidates for chemotherapy. We found that activation of AMPK by all fluorinated N,N-diarylureas (FND) compounds at micromolar levels significantly inhibited the cell cycle progression and subsequent cellular proliferation. Additionally, we demonstrated that select FNDs significantly increased apoptosis in CRC metastatic and cancer stem cells. Therefore, FNDs hold considerable promise in the treatment of metastatic CRC, through elimination of both regular cancer cells and cancer stem cells.
机译:结直肠癌(CRC)是美国癌症相关死亡率的第二大诱因。超过50%的CRC患者会发生局部复发或远处器官转移。癌细胞干细胞在癌细胞的存活和转移中起主要作用。在这项研究中,我们检查了新型AMP激活蛋白激酶(AMPK)激活化合物对CRC转移和干细胞系的影响,将其作为化疗的潜在候选药物。我们发现,由微摩尔水平的所有氟化N,N-二芳基脲(FND)化合物激活的AMPK会显着抑制细胞周期进程和随后的细胞增殖。另外,我们证明了选择的FNDs显着增加了CRC转移和癌症干细胞的凋亡。因此,通过消除常规癌细胞和癌干细胞,FND在转移性CRC的治疗中具有广阔的前景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号